Imagine seeing this announcement and deciding to try and rage bait, all because stocks you own aren't performing. I wish we had someone like Mason trying to refute the pre-clinical, clinical and future clinical instances of Bisantrene, but unfortunately we just have people who ask ''Wait why is a CEO on Hotcopper lol'' and its mind numbing. Please try to contribute productively, regardless of your sentiment.
I encourage other posters to set to ignore, as I will be.
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant, page-32
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.030(1.61%) |
Mkt cap ! $311.7M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.79 | $169.3K | 92.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 3472 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |